Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Mighty Therapeutics

Mighty Therapeutics

Stage unknownUS
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
$150Msum of rounds with a disclosed amount only
Named investors
0
Financing history
1 rounds
  1. Jul 14, 2026
    Funding round · $150M (disclosed)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “Mighty Therapeutics Secures Up to $150 Million to Progress Commercial and Clinical Development of New Class of Mitochondrial Targeted Medicines”
Investors on record
0 edges
No named investor yet.
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
  1. Jul 14, 2026
    Mighty Therapeutics announced Funding round of $150,000,000
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
1 observations
Every observation on this company